Orion Capital Management’s Avita Medical RCEL Stock Holding History

Orion Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$4.81K	–	491
2024 Q1	$4.81K	Hold	300	–	–	﹤0.01%	424
2023 Q4	$4.12K	Hold	300	–	–	﹤0.01%	437
2023 Q3	$4.38K	Buy	+300	New	+$5.08K	﹤0.01%	420
2023 Q2	–	Sell	-300	Closed	-$4.19K	–	361
2023 Q1	$4.19K	Sell	300 -125	-29%	-$1.33K	﹤0.01%	410
2022 Q4	$2.81K	Hold	425	–	–	﹤0.01%	367
2022 Q3	$2K	Hold	425	–	–	﹤0.01%	384
2022 Q2	$2K	Hold	425	–	–	﹤0.01%	400
2022 Q1	$4K	Hold	425	–	–	﹤0.01%	383
2021 Q4	$5K	Hold	425	–	–	﹤0.01%	347
2021 Q3	$8K	Hold	425	–	–	﹤0.01%	314
2021 Q2	$9K	Hold	425	–	–	0.01%	268
2021 Q1	$8K	Hold	425	–	–	0.01%	263
2020 Q4	$8K	Buy	+425	New	+$9.32K	0.01%	260

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Orion Capital Management's RCEL Position: Q2 2024 in Review

Orion Capital Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 300 shares — an estimated $4.81K sold.

Orion Capital Management first reported a position in RCEL in Q4 2020 and held it in 13 quarters. The position peaked at $9K in Q2 2021. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

Orion Capital Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
Orion Capital Management sold 300 Avita Medical shares in Q2 2024, an estimated $4.81K.
Orion Capital Management first reported a position in Avita Medical in Q4 2020 and held it in 13 quarters.
Orion Capital Management's Avita Medical position peaked at $9K in Q2 2021.
68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.